Activin and Inhibin

CP-346086 is a potent and orally active microsomal triglyceride transfer protein (MTP) inhibitor, with an IC 50 of 2.0 nM for human and rodent MTP. CP-346086 can lower plasma cholesterol and triglycerides in vivoIn VitroCP-346086 (0.1-1000 nM)

CP-409092 hydrochloride is a partial agonist of GABA A receptor , with anti-anxiety activity.Form:Solid.

CP-409092 hydrochloride is a partial agonist of GABA A receptor , with anti-anxiety activity.Form:Solid.

CP-409092 hydrochloride is a partial agonist of GABA A receptor , with anti-anxiety activity.Form:Solid.

CP-409092 hydrochloride is a partial agonist of GABA A receptor , with anti-anxiety activity.Form:Solid.

CP-409092 hydrochloride is a partial agonist of GABA A receptor , with anti-anxiety activity.

CP-532623 is a CETP inhibitor and elevates high-density lipoprotein cholesterolion. CP-532623 is a close structural analogue of Torcetrapib. CP-532623 has highly lipophilic propertiesIn VitroCP-532623 is highly lymphatically transported (28% of

CP-532623 is a CETP inhibitor and elevates high-density lipoprotein cholesterolion. CP-532623 is a close structural analogue of Torcetrapib. CP-532623 has highly lipophilic propertiesIn VitroCP-532623 is highly lymphatically transported (28% of

CP-609754 (LNK-754) is a potent and reversible farnesyltransferase inhibitor with potential anticancer activity.The IC 50 for inhibiting farnesylation of recombinant human H-Ras is 0.57 ng/mL and recombinant K-Ras is 46 ng/mL.In VitroCP-609754

CP-609754 (LNK-754) is a potent and reversible farnesyltransferase inhibitor with potential anticancer activity.The IC 50 for inhibiting farnesylation of recombinant human H-Ras is 0.57 ng/mL and recombinant K-Ras is 46 ng/mL.In VitroCP-609754

CP-609754 (LNK-754) is a potent and reversible farnesyltransferase inhibitor with potential anticancer activity.The IC 50 for inhibiting farnesylation of recombinant human H-Ras is 0.57 ng/mL and recombinant K-Ras is 46 ng/mL.In VitroCP-609754

CP-609754 (LNK-754) is a potent and reversible farnesyltransferase inhibitor with potential anticancer activity.The IC 50 for inhibiting farnesylation of recombinant human H-Ras is 0.57 ng/mL and recombinant K-Ras is 46 ng/mL.In VitroCP-609754